Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
ACE and SGLT2 inhibitors: the future for non-diabetic and diabetic proteinuric renal disease — Norberto Perico (2017) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
ACE and SGLT2 inhibitors: the future for non-diabetic and diabetic proteinuric renal disease
Shared by
Giuseppe Remuzzi
ACE and SGLT2 inhibitors: the future for non-diabetic and diabetic proteinuric renal disease
Article
2017
en
Authors
NP
Norberto Perico
PR
Piero Ruggenenti
Giuseppe Remuzzi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2000
ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1
Annalisa Perna
,
Piero Ruggenenti
,
A. Testa
,
Belinda Spoto
,
Roberto Benini
,
V. Misefari
,
Giuseppe Remuzzi
,
Carmine Zoccali
Article
2001
ACE Inhibitors to Prevent End-Stage Renal Disease
Piero Ruggenenti
,
Annalisa Perna
,
Giuseppe Remuzzi
Article
1997
Progression of proteinuric diabetic and nondiabetic renal diseases: a possible role for renal endothelin.
Giuseppe Remuzzi
,
Ariela Benigni
Article
1999
Non-diabetic nephropathies and ACE inhibition
Piero Ruggenenti
,
Annalisa Perna
,
Giuseppe Remuzzi
Article
1997
Angiotensin-converting enzyme inhibitor therapy for non-diabetic progressive renal disease
Piero Ruggenenti
,
Giuseppe Remuzzi
.webp)
Discussion(0)
No comments yet. Be the first to comment.